Windtree Therapeutics Ownership 2024 | Who Owns Windtree Therapeutics Now?

OverviewFinancials Chart

Institutional Ownership

0.00%

Insider Ownership

4.01%

Institutional Holders

1.00

Windtree Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

Windtree Therapeutics's largest institutional shareholder is PARALLEL ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

The largest Windtree Therapeutics shareholder by % of total assets is PARALLEL ADVISORS, LLC. The company owns 0.00 shares of Windtree Therapeutics (WINT), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Windtree Therapeutics's largest institutional buyer is PARALLEL ADVISORS, LLC. The company purchased -1.00 stocks of WINT, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Windtree Therapeutics's biggest institutional seller is PARALLEL ADVISORS, LLC. The company sold -1.00 shares of WINT, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PARALLEL ADVISORS, LLC	-	-	-	-1	-100.00%	-	Mar 31, 2024

Windtree Therapeutics's largest sold out institutional shareholder by shares sold is PARALLEL ADVISORS, LLC, sold -1.00 shares, valued at -, as of undefined.

Windtree Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	156,676	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	168,233	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	41,640	-41,640	-50.00%	Mar 31, 2024
NORTHERN FUNDS	0.00%	14,087	-	-	Mar 28, 2024
FIDELITY CONCORD STREET TRUST	0.00%	14,159	-	-	Feb 29, 2024
Blackstone Alternative Investment Funds	0.00%	1,400	-	-	Mar 31, 2023
EQ ADVISORS TRUST	0.00%	4,060	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	44,600	-	-	Mar 31, 2024

Windtree Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 156.68K shares, compromising 0.00% of its total assets.

Windtree Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	1	-
30 Sep, 23	1	-
30 Jun, 23	1	-50.00%
31 Mar, 23	2	-92.00%
31 Dec, 22	25	31.58%
30 Sep, 22	19	5.56%
30 Jun, 22	18	-14.29%
31 Mar, 22	21	-4.55%
31 Dec, 21	22	29.41%
30 Sep, 21	17	-29.17%
30 Jun, 21	24	60.00%
31 Mar, 21	15	36.36%
31 Dec, 20	11	22.22%
30 Sep, 20	9	50.00%
30 Jun, 20	6	-

As of 31 Dec 23, 1 institutions are holding Windtree Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	1	-
30 Sep, 23	1	-
30 Jun, 23	1	-83.33%
31 Mar, 23	6	-100.00%
31 Dec, 22	1,588,861	-7.54%
30 Sep, 22	1,718,364	7.63%
30 Jun, 22	1,596,488	3.85%
31 Mar, 22	1,537,340	-9.97%
31 Dec, 21	1,707,521	16.65%
30 Sep, 21	1,463,815	-14.98%
30 Jun, 21	1,721,779	55.22%
31 Mar, 21	1,109,251	56.46%
31 Dec, 20	708,987	-2.51%
30 Sep, 20	727,226	207.71%
30 Jun, 20	236,335	-

Windtree Therapeutics (WINT) has 1.00 shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	-	-
30 Sep, 23	-	214100.00%
30 Jun, 23	0.00%	23814.29%
31 Mar, 23	0.00%	0.00%
31 Dec, 22	4.27%	14.00%
30 Sep, 22	5.52%	18.46%
30 Jun, 22	5.47%	18.52%
31 Mar, 22	5.43%	11.41%
31 Dec, 21	6.90%	19.72%
30 Sep, 21	5.91%	4.89%
30 Jun, 21	11.00%	21.90%
31 Mar, 21	7.09%	34.55%
31 Dec, 20	4.53%	20.99%
30 Sep, 20	4.65%	203.82%
30 Jun, 20	1.51%	-

As of 31 Dec 23, Windtree Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-
31 Mar, 23	-	-100.00%
31 Dec, 22	14	55.56%
30 Sep, 22	9	-10.00%
30 Jun, 22	10	-23.08%
31 Mar, 22	13	44.44%
31 Dec, 21	9	-
30 Sep, 21	9	-52.63%
30 Jun, 21	19	72.73%
31 Mar, 21	11	175.00%
31 Dec, 20	4	-20.00%
30 Sep, 20	5	-16.67%
30 Jun, 20	6	-

- institutional shareholders have increased their position in WINT stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	-	-
30 Sep, 23	-	-
30 Jun, 23	-	-100.00%
31 Mar, 23	2	-50.00%
31 Dec, 22	4	-
30 Sep, 22	4	100.00%
30 Jun, 22	2	-50.00%
31 Mar, 22	4	33.33%
31 Dec, 21	3	-
30 Sep, 21	3	200.00%
30 Jun, 21	1	-
31 Mar, 21	1	-66.67%
31 Dec, 20	3	200.00%
30 Sep, 20	1	-
30 Jun, 20	-	-

- institutional shareholders have reduced their position in WINT stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	1	-	1	-	-	-	-	-	-	-
30 Sep, 23	1	-	1	-	-	214100.00%	-	-	-	-
30 Jun, 23	1	-50.00%	1	-83.33%	0.00%	23814.29%	-	-	-	-100.00%
31 Mar, 23	2	-92.00%	6	-100.00%	0.00%	0.00%	-	-100.00%	2	-50.00%
31 Dec, 22	25	31.58%	1,588,861	-7.54%	4.27%	14.00%	14	55.56%	4	-
30 Sep, 22	19	5.56%	1,718,364	7.63%	5.52%	18.46%	9	-10.00%	4	100.00%
30 Jun, 22	18	-14.29%	1,596,488	3.85%	5.47%	18.52%	10	-23.08%	2	-50.00%
31 Mar, 22	21	-4.55%	1,537,340	-9.97%	5.43%	11.41%	13	44.44%	4	33.33%
31 Dec, 21	22	29.41%	1,707,521	16.65%	6.90%	19.72%	9	-	3	-
30 Sep, 21	17	-29.17%	1,463,815	-14.98%	5.91%	4.89%	9	-52.63%	3	200.00%
30 Jun, 21	24	60.00%	1,721,779	55.22%	11.00%	21.90%	19	72.73%	1	-
31 Mar, 21	15	36.36%	1,109,251	56.46%	7.09%	34.55%	11	175.00%	1	-66.67%
31 Dec, 20	11	22.22%	708,987	-2.51%	4.53%	20.99%	4	-20.00%	3	200.00%
30 Sep, 20	9	50.00%	727,226	207.71%	4.65%	203.82%	5	-16.67%	1	-
30 Jun, 20	6	-	236,335	-	1.51%	-	6	-	-	-

Windtree Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 28, 2023	Fraser Craig	director, officer	President and CEO	P-Purchase	Buy	2,500	$1.02	$2.55K	57,877
Sep 27, 2023	Fraser Craig	director, officer	President and CEO	P-Purchase	Buy	2,500	$0.90	$2.25K	55,377

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Sep 28, 2023	Fraser Craig	director, officer	President and CEO	P-Purchase	Buy	2,500	$1.02	$2.55K	57,877
Sep 27, 2023	Fraser Craig	director, officer	President and CEO	P-Purchase	Buy	2,500	$0.90	$2.25K	55,377

Insider Sells

Date	Name	Relation	Role	Buy/Sell	Shares	Price	Value	Shares Held
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	-	-	-	10,233
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	15,000	$1.21	$18.15K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	1	$6.99K	$6.99K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	2	$5.31K	$10.62K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	5	$3.69K	$18.45K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	200	$592.50	$118.50K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	220	$272.00	$59.84K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO	Sell	372	$51.00	$18.97K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 14, 2024	PELLETIER SAUNDRA L	director			Buy	-	-	-	-
Aug 14, 2024	Latkin Jed	director			Buy	-	-	-	-
Jul 24, 2024	Simonson Steven	officer	SVP, Chief Medical Officer	A-Award	Buy	2,674	$4.11	$10.99K	2,674
Jul 24, 2024	Simonson Steven	officer	SVP, Chief Medical Officer	A-Award	Buy	13	-	-	13
Jul 24, 2024	Fraser Craig	director, officer	President and CEO	A-Award	Buy	4,011	$4.11	$16.49K	4,011
Jul 24, 2024	Fraser Craig	director, officer	President and CEO	A-Award	Buy	19	-	-	19
Sep 28, 2023	Fraser Craig	director, officer	President and CEO	P-Purchase	Buy	2,500	$1.02	$2.55K	57,877
Sep 27, 2023	Fraser Craig	director, officer	President and CEO	P-Purchase	Buy	2,500	$0.90	$2.25K	55,377
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	-	-	-	10,233
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Buy	-	-	-	1
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	15,000	$1.21	$18.15K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	1	$6.99K	$6.99K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	2	$5.31K	$10.62K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	5	$3.69K	$18.45K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	200	$592.50	$118.50K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	220	$272.00	$59.84K	-
Sep 05, 2023	McAndrew Jamie	officer	VP, Controller, & CAO		Sell	372	$51.00	$18.97K	-
Aug 29, 2023	Geffken Daniel E.	director	-	A-Award	Buy	3,050	$1.21	$3.69K	3,050
Aug 29, 2023	Geffken Daniel E.	director	-	A-Award	Buy	2,033	-	-	2,175
Aug 25, 2023	Williams Leslie J.	director	-	A-Award	Buy	3,050	$1.21	$3.69K	3,050

The last insider sell of Windtree Therapeutics's stock was made by McAndrew Jamie on Sep 05 2023, selling - shares at - per share (valued at -). The last insider buy of WINT was made by Fraser Craig on Sep 28 2023, buying 2,500 shares at $1.02 per share (worth $2.55K).

Windtree Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	4	-	-
Q3 2023	16	8	200.00%
Q2 2023	2	-	-
Q1 2023	3	9	33.33%
Q3 2022	3	-	-
Q2 2022	7	-	-
Q1 2022	14	-	-
Q4 2021	6	1	600.00%
Q3 2021	1	-	-
Q2 2021	9	-	-
Q1 2021	22	-	-
Q4 2020	6	-	-
Q3 2020	2	-	-
Q2 2020	27	6	450.00%
Q1 2020	8	-	-
Q4 2019	10	-	-
Q2 2019	6	-	-
Q1 2019	8	12	66.67%
Q4 2018	23	18	127.78%
Q2 2018	2	1	200.00%

4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Windtree Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q3 2023	2	-	-
Q2 2023	2	-	-
Q1 2023	-	-	-
Q3 2022	3	-	-
Q2 2022	2	-	-
Q1 2022	3	-	-
Q4 2021	6	1	600.00%
Q3 2021	-	-	-
Q2 2021	7	-	-
Q1 2021	8	-	-
Q4 2020	6	-	-
Q3 2020	-	-	-
Q2 2020	27	-	-
Q1 2020	8	-	-
Q4 2019	9	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	7	-	-
Q2 2018	2	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Windtree Therapeutics's stocks.

Windtree Therapeutics Peer Ownership

Ticker	Company
CFRX	ContraFect Corporation
LIXT	Lixte Biotechnology Holdings, Inc.
NRBO	NeuroBo Pharmaceuticals, Inc.
ATXI	Avenue Therapeutics, Inc.
PALI	Palisade Bio, Inc.

WINT Ownership FAQ

Who Owns Windtree Therapeutics?

Windtree Therapeutics is owned by institutional shareholders (0%), insiders (4.01%), and public (0%). The largest institutional shareholder of Windtree Therapeutics is PARALLEL ADVISORS, LLC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Windtree Therapeutics?

Windtree Therapeutics's major institutional shareholders are PARALLEL ADVISORS, LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Windtree Therapeutics shareholders are there?

As of Dec 2023, there are 1 institutional shareholders of Windtree Therapeutics.

What percentage of Windtree Therapeutics is owned by PARALLEL ADVISORS, LLC?

PARALLEL ADVISORS, LLC owns 0 shares of Windtree Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).